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 The dose-response association between physical activity and cardiovascular outcomes is well 
described (10). As little as 15 min/day of moderate-intensity exercise significantly lowers the 
risk for cardiovascular morbidity and mortality. Greater volumes yield greater cardiovascular 
benefit. However, the impact of extreme volumes of exercise on cardiovascular health is under 
debate (9), since some studies present evidence of adverse clinical outcomes in endurance 
athletes who perform exercise volumes at the extreme upper end of the physical activity 
continuum. These observations raise the possibility that high doses of exercise have deleterious 
cardiac effects.  
 
Potential acute cardiac complications 
Among the early evidence of adverse cardiac effects in athletes was the observation that joggers 
in Rhode Island had a 7 times higher risk of sudden cardiac death (SCD) during exercise 
compared to rest (26). Nevertheless, the relative risk (RR) of an exercise-induced SCD was 
significantly higher in men with low levels of habitual physical activity (RR=56, 95%CI: 23-
131) compared to men who perform the highest level of habitual activity (RR=5, 95%CI: 2-14) 
(24). The incidence of cardiac arrest among athletes is considered low, and estimated at 1 per 
200,000 during marathon running (12). The risk appears to be higher in men (0.9 per 100,000 
runners) versus women (0.16 per 100,000 runners), and bystander cardiopulmonary 
resuscitation and a non-hypertrophic cardiomyopathy cause of SCD are significant predictors 
of survival in collapsed runners (12). 
 SCD with exercise is rare, but exercise-induced increase of cardiac troponin 
concentrations is common (23). In fact, every runner participating in a Boston Marathon study 
demonstrated a post-exercise increase in cardiac troponin subunit I, and 54% of the study 
population exceeded the cut-point for diagnosing a myocardial infarction (8). Although an 
increase in cardiac troponin concentrations is associated with non-reversible cardiac damage in 
clinical populations, it is possible that this exercise-induced release does not represent cardiac 
damage (23). The observation that troponin concentrations return to baseline values below the 
clinical threshold within 24 – 72 hours post-exercise reinforce this hypothesis (21).  
 Performance of endurance exercise also affects structure and function of the cardiac 
chambers. A study in triathletes found a reduction in left ventricular and left and right atrial 
sizes following the Hawaii Ironman Triathlon (6). Furthermore, significant reductions in left 
and right ventricular ejection fraction have been observed in athletes performing prolonged 
exercise (14, 17), with larger decrements in the right heart. The greater vulnerability of the right 
ventricle is due to the exposure of a substantial exercise-induced increase in wall stress (≈125%) 
imposed on its thin wall compared to a moderate increase in wall stress (≈4%) of the thick wall 
of the left ventricle (15). All changes in cardiac function are believed to be transient, with a 
recovery to normal function within 24 to 48 hours post-exercise.   
 
Potential long-term cardiac complications 
The possibility that high volumes of lifelong exercise training may lead to adverse cardiac 
remodeling and subsequent development of cardiovascular diseases is known as the “Too much 
exercise hypothesis”. Although evidence is conflicting (7), some observations are noteworthy. 
For example, myocardial fibrosis (i.e. scarring of cardiac tissue) have been found in endurance 
athletes. A total of 14 studies used cardiac magnetic resonance imaging to assess the presence 
of cardiac scarring and found myocardial fibrosis in 30 of the 509 athletes (5.9%) (27). 
Interestingly, the prevalence of myocardial fibrosis varied between 2.1% and 50% of the study 
population. More years of exercise training and a greater number of completed marathons and 
ultramarathons were associated with the risk for myocardial fibrosis (28). The majority of the 
athletes demonstrated fibrosis near the right ventricular insertion points or within the 
intraventricular septum. The location of the areas may suggest that the development of 
myocardial fibrosis results from repetitive exposure to myocardial micro-trauma and/or to 
exercise-induced dilatation of the right ventricle (27). 
 Another intriguing observation is the potential risk for accelerated atherosclerotic 
coronary artery disease in athletes. A German study found increased coronary artery 
calcification (CAC) scores in middle-aged runners who participated in ≥5 marathons compared 
to an age and Framingham risk score matched control group (18). These findings were 
reinforced by an American study, which showed that total coronary plaque volume (200 versus 
126 mm3, p< 0.01), calcified plaque volume (84 versus 44 mm3, p<0.0001) and non-calcified 
plaque volume (116 versus 82 mm3, p=0.04) were all higher in marathoners compared to 
controls (22). The underlying mechanisms responsible for the increased coronary artery 
calcification in runners are currently unknown, but exercise-induced disruption of laminar flow 
and/or acute, exercise-induced increases in parathyroid hormone levels (3)may contribute to 
accelerated calcification. It is also not clear that the increased CAC score are threatening since 
dense coronary calcification is associated with a lower risk for future cardiovascular events (4).  
 The association between physical activity patterns and the risk for atrial fibrillation (AF) 
appears to be a J-shaped curve. Data from the CARDIOrespiratory FITness study demonstrated 
that fit AF patients had a lower risk for AF recurrences during follow-up compared to unfit AF 
individuals (20). Also, AF patients who increased their physical fitness during an exercise 
program had a greater ablation-free drug-free freedom form AF compared to AF patients who 
failed to improve their fitness (20). In contrast, among those athletes at the upper end of the 
physical activity spectrum, there appears to be an increased risk of AF.  Swedish cross-country 
skiers who participated in more cross-country races (hazard ratio (HR): 1.29, 95%CI: 1.04 – 
1.61) or had faster finishing times (HR: 1.20, 95%CI: 0.93 – 1.55) were at greater risk for AF 
(1). Furthermore, others have reported a significant association between years of exercise 
training and the risk for AF and atrial flutter in Norwegian cross-country skiers (19). These 
observations clearly show that both physically inactive individuals and high exercise volume 
endurance athletes are at an increased risk for AF, whereas moderate exercise training reduces 
AF risk. The exercise training induced increase in vagal tone and left atrial enlargement may 
contribute to the higher AF risk in athletes (25).  
 
Genetic vulnerability to exercise 
There is also evidence that exercise may accelerate the development of cardiac complications 
in individuals with genetic mutations. A retrospective study including 87 desmosome mutation 
carriers for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) found that 
mutation carriers who were endurance athletes (n=56) developed symptoms at a younger age, 
were more likely to meet the ARVD/C disease criteria (82% versus 35%, p<0.001), and had a 
lower lifetime survival free of ventricular arrhythmias (p=0.013) and heart failure (p=0.004) 
compared to non-athlete mutation carriers (n=31) (11). These findings are consistent with 
several animal studies. Age-related increase in right ventricular volume was significantly 
greater in heterozygous plaktoglobin-deficient mice compared to wildtype mice (13). 
Furthermore, the presentation of ARVD/C phenotype appeared to be accelerated by exercise 
training in plaktoblobin-deficient mice but not in wildtype mice. Similar findings were observed 
in plakophillin-2 (5) and desmoplakin deficient mice (16), suggesting that exercise training 
accelerates ARVD/C development in mutation carriers. Whether genotype to phenotype 
development is also accelerated in other genetic cardiac diseases such as hypertrophic 
cardiomyopathy and long QT syndrome is currently unknown.  
 
Conclusion 
The performance of endurance exercise has direct effects on the heart. Most potentially 
deleterious responses appear to be transient (troponin release, cardiac dysfunction) or very rare 
(sudden cardiac arrest/death). There is increasing interest in the cardiac effects of lifelong 
exposure to high volumes of exercise training.  Recent studies suggest that lifelong endurance 
athletes have an increased prevalence of myocardial fibrosis and coronary artery calcification 
compared to non-exercising peers. The clinical implications of these observations are unknown, 
but the causes and significance of these findings may differ between athletes and patients. 
Although exercise improves cardiovascular health and longevity for the majority of the 
(athletic) population (2), it may accelerate the genotype to phenotype development in mutation 
carriers of some genetic cardiac diseases.   
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